Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Lohse

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Iscience|July 24, 2025
Fragments of viral surface proteins modulate innate immune responses via formyl peptide receptorsHeiko Heilmann, Lukas Busch, Celine Buchmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 27, 2012
Impact of epidermal growth factor receptor (EGFR) cell surface expression levels on effector mechanisms of EGFR antibodiesStefanie Derer, Philip Bauer, Stefan Lohse, et al.
Mabs|February 5, 2014
Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicityStefanie Derer, Pia Glorius, Martin Schlaeth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2015
A Complement-Optimized EGFR Antibody Improves Cytotoxic Functions of Polymorphonuclear Cells against Tumor CellsStefanie Derer, Michael Cossham, Thies Rösner, et al.
Frontiers in Cellular and Infection Microbiology|March 21, 2024
The cutaneous beta human papillomavirus type 8 E6 protein induces CCL2 through the CEBPα/miR-203/p63 pathway to support an inflammatory microenvironment in epidermodysplasia verruciformis skin lesionsLuca Vella, Anna Sternjakob, Stefan Lohse, et al.
Cancer Science|March 25, 2010
Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cellsMartin Schlaeth, Sven Berger, Stefanie Derer, et al.
Open Forum Infectious Diseases|August 19, 2021
Rapid Base-Specific Calling of SARS-CoV-2 Variants of Concern Using Combined RT-PCR Melting Curve Screening and SIRPH TechnologySascha Tierling, Kathrin Kattler, Markus Vogelgesang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2011
Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killingStefan Lohse, Stefanie Derer, Thomas Beyer, et al.
Mabs|February 5, 2014
Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2m(1) antibodyChristina Brunke, Stefan Lohse, Stefanie Derer, et al.
The Journal of Biological Chemistry|June 9, 2012
Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophagesStefan Lohse, Christina Brunke, Stefanie Derer, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Iscience|July 24, 2025
Fragments of viral surface proteins modulate innate immune responses via formyl peptide receptorsHeiko Heilmann, Lukas Busch, Celine Buchmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 27, 2012
Impact of epidermal growth factor receptor (EGFR) cell surface expression levels on effector mechanisms of EGFR antibodiesStefanie Derer, Philip Bauer, Stefan Lohse, et al.
Mabs|February 5, 2014
Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicityStefanie Derer, Pia Glorius, Martin Schlaeth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2015
A Complement-Optimized EGFR Antibody Improves Cytotoxic Functions of Polymorphonuclear Cells against Tumor CellsStefanie Derer, Michael Cossham, Thies Rösner, et al.
Frontiers in Cellular and Infection Microbiology|March 21, 2024
The cutaneous beta human papillomavirus type 8 E6 protein induces CCL2 through the CEBPα/miR-203/p63 pathway to support an inflammatory microenvironment in epidermodysplasia verruciformis skin lesionsLuca Vella, Anna Sternjakob, Stefan Lohse, et al.
Cancer Science|March 25, 2010
Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cellsMartin Schlaeth, Sven Berger, Stefanie Derer, et al.
Open Forum Infectious Diseases|August 19, 2021
Rapid Base-Specific Calling of SARS-CoV-2 Variants of Concern Using Combined RT-PCR Melting Curve Screening and SIRPH TechnologySascha Tierling, Kathrin Kattler, Markus Vogelgesang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2011
Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killingStefan Lohse, Stefanie Derer, Thomas Beyer, et al.
Mabs|February 5, 2014
Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2m(1) antibodyChristina Brunke, Stefan Lohse, Stefanie Derer, et al.
The Journal of Biological Chemistry|June 9, 2012
Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophagesStefan Lohse, Christina Brunke, Stefanie Derer, et al.
Pageof 5